Email alerts

Subscribe to our mailing list

Testimonials

Since Tri-Solfen® was commercially launched, over 150 million lambs have been treated and over 80% of Australian wool growers are now using Tri-Solfen for their sheep. Here’s what some of them have to say…

‘We have used pain relief for two years now and seen real production gains. We are concerned for the welfare of our animals and will continue to use pain relief to ensure they get the best care.’

Clinton Wise– Wililoo Merino Stud, Woodanilling, W.A.

'It easy to see the difference pain relief makes. Before, lambs would walk away hunched up, even taking a couple of hours to walk back to the paddock. Now they run straight back to Mum and start suckling,” says Rod. “My wool is now sold under the Better Choices brand. I see this as a definite advantage. I think it will be an advantage in the long run, to both me and the industry as a whole.'

Rod Miller– Glenpaen Merino Stud, Horsham, Vic

'After being treated with pain relief my lambs were more content and less stressed. As farmers we are sincere in looking after the welfare of our animals and using pain relief demonstrates this.'

Richard Coole– Frankland, W.A.

'We have been using pain relief for the past three years. We’re impressed by reduced bleeding in the mulesing wound immediately after application. Lambs run straight back to find the ewe, which has dramatically reduced our mortality rates. Flock management, post lamb marking is easier due to the effect of pain relief and the scab healing faster.'

Ryan & Malcom O’Dea– Peepingee Merino Stud, Narrogin, W.A.

'Using pain relief eases the stress and allows lambs to mother up and move back to the paddock easier with faster weight gains.'

Kent Lummis– Waverley Downs, Gilgandra, NSW

Close

Patent Portfolio

Country Species Patent
Australia Sheep Granted
Australia Horses, Dogs, Lab animals Granted
Australia Cattle Granted
Australia Humans Granted
New
Zealand		 Sheep,
Cattle		 Granted
New
Zealand		 Horses, Dogs, Lab animals Granted
EU Humans Granted
EU Pig, Sheep,
Cattle		 Granted
USA Dogs, Horses, Lab animals Granted
USA Humans Granted
USA Pig, Sheep,
Cattle		 Granted
Canada Horses, Dogs, Lab animals Granted
Canada Cattle,
Pig		 Granted
Canada Humans Granted

Close

Advisory Board

Ian Page

Non-Executive Director

Ian is Chief Executive Officer of Dechra Pharmaceuticals, which has a 33% shareholder in Medical Ethics. He joined National Veterinary Services, Dechra’s former services business in 1989 and joined the Board of Dechra in 1997. In October 2010, Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Dr Chris Roberts

Human Wound and Regulatory Advisor

Chris has over 20 years’ line management experience of heading clinical research teams. He was previously global head of Smith & Nephew clinical support and market development, where he managed global clinical Phase II and III programmes in the management of venous and pressure ulcers.

Lieutenant Colonel Professor Steven Jeffery

Medical Specialist Advisor

Steve has over 15 years’ experience in military plastic surgery. In 2011 he was awarded the Military Civilian Partnership Award for ‘Regular of the Year’, as well as receiving the Wounds UK ‘Key Contribution’ award and the Smith and Nephew ‘Customer Pioneer of the Year’ award. He has also been awarded Fellowship of the Royal College of Surgeons of England ad eundum. He is an expert adviser to NICE Medical Technologies Evaluation Programme. Steve co-founded the Woundcare 4 Heroes charity, which is already making a big difference to the wound care of both serving and veteran personnel.

Dr Matthew Bayfield

Medical Specialist Scientific Director

Dr Matthew Bayfield, Head of Cardiothoracic Surgery, Strathfield Private Hospital and VMO Cardiothoracic Surgeon, Royal Prince Alfred Hospital.

Professor Peter Windsor

Veterinarian Research Advisor

Peter is a registered specialist veterinary surgeon in New South Wales and an emeritus Professor at Sydney University. He holds a BVSc (Hons), PhD, DVSc and diploma from the European College of Small Ruminant Health Management.

Dr Julian Braidwood

Global Regulatory Affairs Advisor

Julian has held leadership roles and managed international clinical projects with Grampian. He was previously Regulatory Affairs Manager at Novartis Animal Health. He is the Founder and Managing Director of Triveritas, where he is responsible for a team of 40 animal health specialists across the EU and the US.

Close

WE ARE WORKING TOWARDS MAKING OUR TECHNOLOGY AVAILABLE FOR THE ANIMALS WE SHARE OUR LIVES WITH

Companion animals

Reducing pain and minimising suffering from wounds and surgical procedures

Medical Ethics is working with veterinarians and research partners (ANU and Sydney University) to investigate the use of Tri-Solfen® formulation for pain alleviation following surgical procedures and traumatic wounds in companion animals – including dogs, horses, native animals and laboratory animals.

We believe our transformational way of mitigating pain and minimising suffering associated with wounds will make a real difference for vets treating companion animals in the same way we have witnessed with livestock.

Tri-Solfen®

Tri-Solfen®

Tri-Solfen® is a local anaesthetic and antiseptic spray & stay viscous solution that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improves wound healing. Tri-Solfen® contains two proven topical local anaesthetics; fast-acting Lignocaine for immediate pain relief and long-acting local anaesthetic for prolonged post­operative pain relief. Adrenaline is included for its ability to reduce the shock and stress of blood loss, whilst prolonging the anaesthetic action. Tri-Solfen® also contains Cetrimide; an antiseptic widely used to cleanse skin and wounds and provides protection from bacterial contamination.

Tri-Solfen® is registered, in Australia & New Zealand, for cattle & sheep, only. For further information regarding horses and other animals, please contact your local vet.

Product pipeline    News article

Video

The advantages of using our technology for horses:
Shonnay Smith, a horse owner in Queensland, Australia and her vet Andrew Marland of Vet Cross discuss the advantages of using the Medical Ethics Tri-Solfen® product for horses. In the example shown, a wounded horse not used to being handled is treated with Tri-Solfen® instead of the usual bandaging procedure with impressive results.

Questionnaire for veterinarians

If you are a veterinarian currently using Tri-Solfen® off-label for use with horses, please download and complete our questionnaire. The completion of this questionnaire and returning it to us with your photographs will help us understand the efficacy of the Tri-Solfen® product when used for treatment on horses.

Please return all four pages as a scan, or photographs of the completed pages, along with any photographs of the wound and progression through treatment, or fill the questionnaire in using Adobe Acrobat and return it to us (for details see questionnaire).

Off-label use in horses

Download